Pharmaxis Encouraged by First Results in Bone Marrow Cancer Trial

30th Jun 21

Release Date: 30/06/2021 3:00pm

Pharmaxis CEO Gary Phillips speaks to Proactive Investors about the myelofibrosis clinical trial which is being conducted with patients in Australia and South Korea and the potential for other cancer indications.

Watch the interview here.  

Categories: Video Content